Issues

mumps_vaccine

University Officials Push to Vaccinate More Students and Employees Against Mumps

Prior to the introduction of a routine vaccination program in the United States, mumps was a common illness in infants, children, and young adults. Although many individuals have received the mumps vaccination, thereby significantly reducing the number of incidences of mumps in the U.S., a recent outbreak... [continue reading]

generic_drugs

Pharmacists Struggle with Price Increases for Generic Medications

Identical to a brand name drug in dosage form, safety, strength, quality and intended use, generic drugs have saved “consumers an estimated $8 to $10 billion a year at retail pharmacies.” Yet in the past year, the cost for a number of generic drugs has spiked for... [continue reading]

biologics

Patients in the United States Continue to Struggle with the High Cost of Biologic Drugs

In the United States, patients such as Philip DeLuca with chronic conditions rely on a revolutionary class of drugs called “biologics” to stay healthy. Retired and living on a pension, the cost of the weekly injection for the 71 year old is “financially difficult” but for Mr.... [continue reading]

pharmacist50

Expanding Pharmacists’ Scope of Practice to Improve Access to Health Care

Nationwide, many states are grappling with how to ensure convenient access to quality health care for their residents. In states such as Washington, as more and more individuals gain access to health insurance, health care officials are seeking ways to “spread the work of providing health care... [continue reading]

pharmacist11

Transition Period Sought for Implementation of Medicaid Reimbursement Rates for Generic Prescription Drugs

Concerned about the Centers for Medicare and Medicaid Services’ (CMS) plans to implement this summer “a new provision under the Affordable Care Act (ACA) that would significantly reduce Medicaid reimbursement rates for generic prescription drugs,” a coalition of drug makers and pharmacists have requested CMS to “allow... [continue reading]